Evaluating the impact of different positron emitters on the performance of a clinical PET/MR system

Abstract

The positron range and prompt gamma emission are distinctive with different positron emitters. The performance assessment of an integrated PET/MR scanner with these positron emitters is required for related applications, as the magnetic field interferes with the positron propagation. Such an assessment is to be performed on the United Imaging uPMR 790-integrated PET/MR system. Methods: The performance measurement methods were modified based on NEMA NU 2-2012, involving 18 F, 64 Cu, 68 Ga, 89 Zr, and 124 I as positron emitters. The NEMA IEC phantom was used for evaluations of image qualities. An agarose cap was wrapped around the point source for tissue-simulating spatial resolution measurement. The count rate performance was assessed with selected positron emitters. Images of a 3D-printed Derenzo phantom and representative patients were also acquired. Results:The image quality measurement showed that all five positron emitters were suitable for the PET/MR system studied. However, due to the magnetic field, the image of the point source showed an elongated comet-tail feature, which could be eliminated by a tissue-simulating cap. This effect is more obvious in 124 I and 68 Ga, due to their long positron ranges. The imaging ability with various positron emitters was further validated with the count rate assessment, the Derenzo phantom, and the clinical images. Conclusions: Different positron emitters could be effectively imaged by the PET/MR system tested. The resolution measurement strategy proposed could be applied to measure PET spatial resolution in the magnetic field.

Preclinical Evaluation and Pilot Clinical Study of 18F-Labeled Inhibitor Peptide for Noninvasive Positron Emission Tomography Mapping of Angiotensin Converting Enzyme 2

“…The significant advance of this new clinical trial is that fluorine-18, the most widely used nuclide in contemporary PET/CT, has a more favorable half-life and improved imaging properties than gallium-68 and copper-64, which leads to better patient compliance in clinical trials and more efficient and accurate diagnosis. Second, by relying on accelerator production, 18 F-labeled drugs can be supplied to 100 people in a single batch, which means greatly reduced costs and improved efficiency, which is the direction of capital investment required for clinical translation.…”

A review of harmonization strategies for quantitative PET

“…Some studies have investigated PET image characteristics of different radioisotopes [ 114 , 118 ]. Soderlund et al [ 113 ] evaluated the image quality and spatial resolution for a set of radioisotopes ( 18 F, 11 C, 89 Zr, 124 I, 68 Ga and 90 Y).…”

Recent Advances in Positron Emission Tomography/Magnetic Resonance Imaging Technology

“…8 Reduced positron range and improved PET image quality (higher spatial resolution) are expected for high-energy positron-emitting PET radiotracers due to the presence of the MR magnetic field in simultaneous PET MR imaging at high magnetic field strength. 9 Moreover, co-registered MR data (in simultaneous PET/MR imaging) could be employed for MRI-guided PET image reconstruction and partial volume correction to enhance the overall quality and quantitative accuracy of PET images. 10,11 Despite the advantages associated with simultaneous PET/MR imaging, this technology yet faces major challenges regarding attenuation correction for PET data, mutual MR-PET components interferences, body truncation due to the limited transaxial MR field-of-view, and artifacts in MR images due to the metal implants.…”